PARALLAX
A 24-week, study to evaluate the effect of LCZ696 on NT-proBNP, symptoms, exercise function and safety compared to individualized medical management of comorbidities in patients with heart failure and preserved ejection fraction
- Stage
- klaar
- Medicine
- Entresto
- Population
- Hartfalen
- Phase
- III
- First Patient In
- 8 January 2018
- Last Patient In
- 7 May 2019
- Last Patient Last Visit
- 31 October 2019
National Lead
